Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Chronic kidney disease in primary care : risk of cardiovascular events, end stage kidney disease and death. / Borg, Rikke; Kriegbaum, Margit; Grand, Mia Klinten; Lind, Bent; Andersen, Christen Lykkegaard; Persson, Frederik.

In: BMC Primary Care, Vol. 24, No. 1, 128, 2023.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Borg, R, Kriegbaum, M, Grand, MK, Lind, B, Andersen, CL & Persson, F 2023, 'Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death', BMC Primary Care, vol. 24, no. 1, 128. https://doi.org/10.1186/s12875-023-02077-7

APA

Borg, R., Kriegbaum, M., Grand, M. K., Lind, B., Andersen, C. L., & Persson, F. (2023). Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death. BMC Primary Care, 24(1), [128]. https://doi.org/10.1186/s12875-023-02077-7

Vancouver

Borg R, Kriegbaum M, Grand MK, Lind B, Andersen CL, Persson F. Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death. BMC Primary Care. 2023;24(1). 128. https://doi.org/10.1186/s12875-023-02077-7

Author

Borg, Rikke ; Kriegbaum, Margit ; Grand, Mia Klinten ; Lind, Bent ; Andersen, Christen Lykkegaard ; Persson, Frederik. / Chronic kidney disease in primary care : risk of cardiovascular events, end stage kidney disease and death. In: BMC Primary Care. 2023 ; Vol. 24, No. 1.

Bibtex

@article{d84c6100936741e8bee26d4ef258db92,
title = "Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death",
abstract = "Background: The prevalence of chronic kidney disease (CKD) is increasing globally. Early diagnosis in primary care may have a role in ensuring proper intervention. We aimed to determine the prevalence and outcome of CKD in primary care. Methods: We performed an observational cohort study in primary care in Copenhagen (2001–2015). Outcomes were stroke, myocardial infarction (MI), heart failure (HF), peripheral artery disease (PAD), all-cause- and cardiovascular mortality. We combined individuals with normal kidney function and CKD stage 2 as reference. We conducted cause-specific Cox proportional regressions to calculate the hazard ratios for outcomes according to CKD group. We explored the associations between kidney function and the outcomes examined using eGFR as a continuous variable modelled with penalised splines. All models were adjusted for age, gender, diabetes, hypertension, existing CVD, heart failure, LDL cholesterol and use of antihypertensive treatment. Results: We included 171,133 individuals with at least two eGFR measurements of which the majority (n = 157,002) had eGFR > 60 ml/min/1.73m2 at index date, and 0.05% were in CKD stage 5. Event rates were low in eGFR > 60 ml/min/1.73m2 but increased in those with higher stages of CKD. In adjusted analyses we observed an increase in hazard rates for every outcome with every increment in CKD stage. Compared to the reference group, individuals in CKD stage 4 had double the hazard rate of PAD, MI, cardiovascular and all-cause mortality. Conclusions: Our data from a large primary care cohort demonstrate an early increase in the risk of adverse outcomes already at CKD stage 3. This underlines the importance of studying early intervention in primary care.",
keywords = "Chronic kidney disease, eGFR, ESKD, Kidney function, Primary care",
author = "Rikke Borg and Margit Kriegbaum and Grand, {Mia Klinten} and Bent Lind and Andersen, {Christen Lykkegaard} and Frederik Persson",
note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",
year = "2023",
doi = "10.1186/s12875-023-02077-7",
language = "English",
volume = "24",
journal = "BMC Primary Care",
issn = "2731-4553",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Chronic kidney disease in primary care

T2 - risk of cardiovascular events, end stage kidney disease and death

AU - Borg, Rikke

AU - Kriegbaum, Margit

AU - Grand, Mia Klinten

AU - Lind, Bent

AU - Andersen, Christen Lykkegaard

AU - Persson, Frederik

N1 - Publisher Copyright: © 2023, The Author(s).

PY - 2023

Y1 - 2023

N2 - Background: The prevalence of chronic kidney disease (CKD) is increasing globally. Early diagnosis in primary care may have a role in ensuring proper intervention. We aimed to determine the prevalence and outcome of CKD in primary care. Methods: We performed an observational cohort study in primary care in Copenhagen (2001–2015). Outcomes were stroke, myocardial infarction (MI), heart failure (HF), peripheral artery disease (PAD), all-cause- and cardiovascular mortality. We combined individuals with normal kidney function and CKD stage 2 as reference. We conducted cause-specific Cox proportional regressions to calculate the hazard ratios for outcomes according to CKD group. We explored the associations between kidney function and the outcomes examined using eGFR as a continuous variable modelled with penalised splines. All models were adjusted for age, gender, diabetes, hypertension, existing CVD, heart failure, LDL cholesterol and use of antihypertensive treatment. Results: We included 171,133 individuals with at least two eGFR measurements of which the majority (n = 157,002) had eGFR > 60 ml/min/1.73m2 at index date, and 0.05% were in CKD stage 5. Event rates were low in eGFR > 60 ml/min/1.73m2 but increased in those with higher stages of CKD. In adjusted analyses we observed an increase in hazard rates for every outcome with every increment in CKD stage. Compared to the reference group, individuals in CKD stage 4 had double the hazard rate of PAD, MI, cardiovascular and all-cause mortality. Conclusions: Our data from a large primary care cohort demonstrate an early increase in the risk of adverse outcomes already at CKD stage 3. This underlines the importance of studying early intervention in primary care.

AB - Background: The prevalence of chronic kidney disease (CKD) is increasing globally. Early diagnosis in primary care may have a role in ensuring proper intervention. We aimed to determine the prevalence and outcome of CKD in primary care. Methods: We performed an observational cohort study in primary care in Copenhagen (2001–2015). Outcomes were stroke, myocardial infarction (MI), heart failure (HF), peripheral artery disease (PAD), all-cause- and cardiovascular mortality. We combined individuals with normal kidney function and CKD stage 2 as reference. We conducted cause-specific Cox proportional regressions to calculate the hazard ratios for outcomes according to CKD group. We explored the associations between kidney function and the outcomes examined using eGFR as a continuous variable modelled with penalised splines. All models were adjusted for age, gender, diabetes, hypertension, existing CVD, heart failure, LDL cholesterol and use of antihypertensive treatment. Results: We included 171,133 individuals with at least two eGFR measurements of which the majority (n = 157,002) had eGFR > 60 ml/min/1.73m2 at index date, and 0.05% were in CKD stage 5. Event rates were low in eGFR > 60 ml/min/1.73m2 but increased in those with higher stages of CKD. In adjusted analyses we observed an increase in hazard rates for every outcome with every increment in CKD stage. Compared to the reference group, individuals in CKD stage 4 had double the hazard rate of PAD, MI, cardiovascular and all-cause mortality. Conclusions: Our data from a large primary care cohort demonstrate an early increase in the risk of adverse outcomes already at CKD stage 3. This underlines the importance of studying early intervention in primary care.

KW - Chronic kidney disease

KW - eGFR

KW - ESKD

KW - Kidney function

KW - Primary care

U2 - 10.1186/s12875-023-02077-7

DO - 10.1186/s12875-023-02077-7

M3 - Journal article

C2 - 37344787

AN - SCOPUS:85162858141

VL - 24

JO - BMC Primary Care

JF - BMC Primary Care

SN - 2731-4553

IS - 1

M1 - 128

ER -

ID: 358640253